Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
853

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogel-Mediated Delivery of Drug Nanocarriers in the Oedematous Postoperative Brain.

Pharmaceutical research·2026
Same author

AI-augmented thyroid scintigraphy for robust classification of disease.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Cycle-dependent variation of tumor absorbed dose rates in<sup>177</sup>Lu-DOTATATE therapies.

Biomedical physics & engineering express·2026
Same author

Beyond the tumor: recurrence-prone radiomics for prognostication in negative PSMA PET/CT scans of prostate cancer.

Biomedical physics & engineering express·2026
Same author

Kernel-based maximum likelihood reconstruction of attenuation and activity (MLAA) in SPECT imaging for improved attenuation correction and activity quantification: simulation, phantom and patient validation studies.

Physics in medicine and biology·2026
Same author

A clinically anchored radiomics dictionary for explainable TI-RADS-based thyroid nodule classification in ultrasound; dictionary version TU1.0.

European journal of radiology·2026

Related Experiment Video

Updated: May 2, 2026

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

7.7K

Radiopharmaceutical transport in solid tumors via a 3-dimensional image-based spatiotemporal model.

Anahita Piranfar1, Farshad Moradi Kashkooli1, Wenbo Zhan2

  • 1Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.

NPJ Systems Biology and Applications
|April 12, 2024
PubMed
Summary

Personalizing Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA) therapy requires understanding drug delivery. A new model simulates 177Lu-PSMA pharmacokinetics in prostate tumors, revealing factors influencing uptake.

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

9.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Related Experiment Videos

Last Updated: May 2, 2026

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

7.7K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

9.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical therapy
  • Computational modeling

Background:

  • 177Lu-PSMA therapy is approved for metastatic castration-resistant prostate cancer (mCRPC).
  • Current treatment often uses a "one size fits all" approach, limiting personalization.
  • Deeper understanding of radiopharmaceutical pharmacokinetics is needed for optimized treatment.

Purpose of the Study:

  • To develop a 3D spatiotemporal model simulating 177Lu-PSMA pharmacokinetics in prostate tumors.
  • To investigate the impact of physiological parameters on radiopharmaceutical delivery.
  • To provide insights for personalized radiopharmaceutical therapy.

Main Methods:

  • Developed a 3D spatiotemporal model incorporating interstitial flow, receptor dynamics, and drug transport.
  • Simulated 177Lu-PSMA pharmacokinetics under varying injection amounts, receptor densities, and recycling rates.
  • Analyzed effects of injection type and convection-diffusion-reaction mechanisms.

Main Results:

  • Increased receptor density, ligand amount, and labeled ligands enhanced tumor uptake.
  • High receptor recycling rates (0.1 min-1) significantly boosted radiopharmaceutical concentration.
  • Continuous infusion yielded higher tumor concentrations than bolus administration.

Conclusions:

  • The model elucidates key factors influencing 177Lu-PSMA delivery in prostate tumors.
  • Personalization of 177Lu-PSMA therapy can be advanced through understanding these parameters.
  • The model provides a framework for analyzing radiopharmaceutical distribution in targeted cancer therapy.